Click for best price
Molecular Diagnosis of Rectal Cancer Market Size, Share 2023
A molecular approach for diagnosing rectal cancer
This report aims to provide a comprehensive presentation of the global market for Molecular Diagnosis of Rectal Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Diagnosis of Rectal Cancer. This report contains market size and forecasts of Molecular Diagnosis of Rectal Cancer in global, including the following market information:
Global Molecular Diagnosis of Rectal Cancer Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Molecular Diagnosis of Rectal Cancer market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
PCR Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Molecular Diagnosis of Rectal Cancer include Kingmed, Geneis, Unitedgene, Yin Feng Gene, Inmedi, Amoydx, Genetronhealth, Berryoncology and Topgen, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Molecular Diagnosis of Rectal Cancer companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Molecular Diagnosis of Rectal Cancer Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Molecular Diagnosis of Rectal Cancer Market Segment Percentages, by Type, 2022 (%)
PCR
FISH
DNA Sequencing
Gene Chip
Global Molecular Diagnosis of Rectal Cancer Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Molecular Diagnosis of Rectal Cancer Market Segment Percentages, by Application, 2022 (%)
Clinical Diagnosis
Drug Screening
Research
Global Molecular Diagnosis of Rectal Cancer Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Molecular Diagnosis of Rectal Cancer Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Molecular Diagnosis of Rectal Cancer revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Molecular Diagnosis of Rectal Cancer revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Kingmed
Geneis
Unitedgene
Yin Feng Gene
Inmedi
Amoydx
Genetronhealth
Berryoncology
Topgen
Roche
Qiagen
Outline of Major Chapters:
Chapter 1: Introduces the definition of Molecular Diagnosis of Rectal Cancer, market overview.
Chapter 2: Global Molecular Diagnosis of Rectal Cancer market size in revenue.
Chapter 3: Detailed analysis of Molecular Diagnosis of Rectal Cancer company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Molecular Diagnosis of Rectal Cancer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Molecular Diagnosis of Rectal Cancer Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
67 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Molecular Diagnosis of Rectal Cancer Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Molecular Diagnosis of Rectal Cancer Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Molecular Diagnosis of Rectal Cancer Overall Market Size
2.1 Global Molecular Diagnosis of Rectal Cancer Market Size: 2022 VS 2030
2.2 Global Molecular Diagnosis of Rectal Cancer Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Molecular Diagnosis of Rectal Cancer Players in Global Market
3.2 Top Global Molecular Diagnosis of Rectal Cancer Companies Ranked by Revenue
3.3 Global Molecular Diagnosis of Rectal Cancer Revenue by Companies
3.4 Top 3 and Top 5 Molecular Diagnosis of Rectal Cancer Companies in Global Market, by Revenue in 2022
3.5 Global Companies Molecular Diagnosis of Rectal Cancer Product Type
3.6 Tier 1, Tier 2 and Tier 3 Molecular Diagnosis of Rectal Cancer Players in Global Market
3.6.1 List of Global Tier 1 Molecular Diagnosis of Rectal Cancer Companies
3.6.2 List of Global Tier 2 and Tier 3 Molecular Diagnosis of Rectal Cancer Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Molecular Diagnosis of Rectal Cancer Market Size Markets, 2022 & 2030
4.1.2 PCR
4.1.3 FISH
4.1.4 DNA Sequencing
4.1.5 Gene Chip
4.2 By Type - Global Molecular Diagnosis of Rectal Cancer Revenue & Forecasts
4.2.1 By Type - Global Molecular Diagnosis of Rectal Cancer Revenue, 2018-2023
4.2.2 By Type - Global Molecular Diagnosis of Rectal Cancer Revenue, 2024-2030
4.2.3 By Type - Global Molecular Diagnosis of Rectal Cancer Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Molecular Diagnosis of Rectal Cancer Market Size, 2022 & 2030
5.1.2 Clinical Diagnosis
5.1.3 Drug Screening
5.1.4 Research
5.2 By Application - Global Molecular Diagnosis of Rectal Cancer Revenue & Forecasts
5.2.1 By Application - Global Molecular Diagnosis of Rectal Cancer Revenue, 2018-2023
5.2.2 By Application - Global Molecular Diagnosis of Rectal Cancer Revenue, 2024-2030
5.2.3 By Application - Global Molecular Diagnosis of Rectal Cancer Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Molecular Diagnosis of Rectal Cancer Market Size, 2022 & 2030
6.2 By Region - Global Molecular Diagnosis of Rectal Cancer Revenue & Forecasts
6.2.1 By Region - Global Molecular Diagnosis of Rectal Cancer Revenue, 2018-2023
6.2.2 By Region - Global Molecular Diagnosis of Rectal Cancer Revenue, 2024-2030
6.2.3 By Region - Global Molecular Diagnosis of Rectal Cancer Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Molecular Diagnosis of Rectal Cancer Revenue, 2018-2030
6.3.2 US Molecular Diagnosis of Rectal Cancer Market Size, 2018-2030
6.3.3 Canada Molecular Diagnosis of Rectal Cancer Market Size, 2018-2030
6.3.4 Mexico Molecular Diagnosis of Rectal Cancer Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Molecular Diagnosis of Rectal Cancer Revenue, 2018-2030
6.4.2 Germany Molecular Diagnosis of Rectal Cancer Market Size, 2018-2030
6.4.3 France Molecular Diagnosis of Rectal Cancer Market Size, 2018-2030
6.4.4 U.K. Molecular Diagnosis of Rectal Cancer Market Size, 2018-2030
6.4.5 Italy Molecular Diagnosis of Rectal Cancer Market Size, 2018-2030
6.4.6 Russia Molecular Diagnosis of Rectal Cancer Market Size, 2018-2030
6.4.7 Nordic Countries Molecular Diagnosis of Rectal Cancer Market Size, 2018-2030
6.4.8 Benelux Molecular Diagnosis of Rectal Cancer Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Molecular Diagnosis of Rectal Cancer Revenue, 2018-2030
6.5.2 China Molecular Diagnosis of Rectal Cancer Market Size, 2018-2030
6.5.3 Japan Molecular Diagnosis of Rectal Cancer Market Size, 2018-2030
6.5.4 South Korea Molecular Diagnosis of Rectal Cancer Market Size, 2018-2030
6.5.5 Southeast Asia Molecular Diagnosis of Rectal Cancer Market Size, 2018-2030
6.5.6 India Molecular Diagnosis of Rectal Cancer Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Molecular Diagnosis of Rectal Cancer Revenue, 2018-2030
6.6.2 Brazil Molecular Diagnosis of Rectal Cancer Market Size, 2018-2030
6.6.3 Argentina Molecular Diagnosis of Rectal Cancer Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Molecular Diagnosis of Rectal Cancer Revenue, 2018-2030
6.7.2 Turkey Molecular Diagnosis of Rectal Cancer Market Size, 2018-2030
6.7.3 Israel Molecular Diagnosis of Rectal Cancer Market Size, 2018-2030
6.7.4 Saudi Arabia Molecular Diagnosis of Rectal Cancer Market Size, 2018-2030
6.7.5 UAE Molecular Diagnosis of Rectal Cancer Market Size, 2018-2030
7 Molecular Diagnosis of Rectal Cancer Companies Profiles
7.1 Kingmed
7.1.1 Kingmed Company Summary
7.1.2 Kingmed Business Overview
7.1.3 Kingmed Molecular Diagnosis of Rectal Cancer Major Product Offerings
7.1.4 Kingmed Molecular Diagnosis of Rectal Cancer Revenue in Global Market (2018-2023)
7.1.5 Kingmed Key News & Latest Developments
7.2 Geneis
7.2.1 Geneis Company Summary
7.2.2 Geneis Business Overview
7.2.3 Geneis Molecular Diagnosis of Rectal Cancer Major Product Offerings
7.2.4 Geneis Molecular Diagnosis of Rectal Cancer Revenue in Global Market (2018-2023)
7.2.5 Geneis Key News & Latest Developments
7.3 Unitedgene
7.3.1 Unitedgene Company Summary
7.3.2 Unitedgene Business Overview
7.3.3 Unitedgene Molecular Diagnosis of Rectal Cancer Major Product Offerings
7.3.4 Unitedgene Molecular Diagnosis of Rectal Cancer Revenue in Global Market (2018-2023)
7.3.5 Unitedgene Key News & Latest Developments
7.4 Yin Feng Gene
7.4.1 Yin Feng Gene Company Summary
7.4.2 Yin Feng Gene Business Overview
7.4.3 Yin Feng Gene Molecular Diagnosis of Rectal Cancer Major Product Offerings
7.4.4 Yin Feng Gene Molecular Diagnosis of Rectal Cancer Revenue in Global Market (2018-2023)
7.4.5 Yin Feng Gene Key News & Latest Developments
7.5 Inmedi
7.5.1 Inmedi Company Summary
7.5.2 Inmedi Business Overview
7.5.3 Inmedi Molecular Diagnosis of Rectal Cancer Major Product Offerings
7.5.4 Inmedi Molecular Diagnosis of Rectal Cancer Revenue in Global Market (2018-2023)
7.5.5 Inmedi Key News & Latest Developments
7.6 Amoydx
7.6.1 Amoydx Company Summary
7.6.2 Amoydx Business Overview
7.6.3 Amoydx Molecular Diagnosis of Rectal Cancer Major Product Offerings
7.6.4 Amoydx Molecular Diagnosis of Rectal Cancer Revenue in Global Market (2018-2023)
7.6.5 Amoydx Key News & Latest Developments
7.7 Genetronhealth
7.7.1 Genetronhealth Company Summary
7.7.2 Genetronhealth Business Overview
7.7.3 Genetronhealth Molecular Diagnosis of Rectal Cancer Major Product Offerings
7.7.4 Genetronhealth Molecular Diagnosis of Rectal Cancer Revenue in Global Market (2018-2023)
7.7.5 Genetronhealth Key News & Latest Developments
7.8 Berryoncology
7.8.1 Berryoncology Company Summary
7.8.2 Berryoncology Business Overview
7.8.3 Berryoncology Molecular Diagnosis of Rectal Cancer Major Product Offerings
7.8.4 Berryoncology Molecular Diagnosis of Rectal Cancer Revenue in Global Market (2018-2023)
7.8.5 Berryoncology Key News & Latest Developments
7.9 Topgen
7.9.1 Topgen Company Summary
7.9.2 Topgen Business Overview
7.9.3 Topgen Molecular Diagnosis of Rectal Cancer Major Product Offerings
7.9.4 Topgen Molecular Diagnosis of Rectal Cancer Revenue in Global Market (2018-2023)
7.9.5 Topgen Key News & Latest Developments
7.10 Roche
7.10.1 Roche Company Summary
7.10.2 Roche Business Overview
7.10.3 Roche Molecular Diagnosis of Rectal Cancer Major Product Offerings
7.10.4 Roche Molecular Diagnosis of Rectal Cancer Revenue in Global Market (2018-2023)
7.10.5 Roche Key News & Latest Developments
7.11 Qiagen
7.11.1 Qiagen Company Summary
7.11.2 Qiagen Business Overview
7.11.3 Qiagen Molecular Diagnosis of Rectal Cancer Major Product Offerings
7.11.4 Qiagen Molecular Diagnosis of Rectal Cancer Revenue in Global Market (2018-2023)
7.11.5 Qiagen Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Molecular Diagnosis of Rectal Cancer Market Opportunities & Trends in Global Market
Table 2. Molecular Diagnosis of Rectal Cancer Market Drivers in Global Market
Table 3. Molecular Diagnosis of Rectal Cancer Market Restraints in Global Market
Table 4. Key Players of Molecular Diagnosis of Rectal Cancer in Global Market
Table 5. Top Molecular Diagnosis of Rectal Cancer Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Molecular Diagnosis of Rectal Cancer Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Molecular Diagnosis of Rectal Cancer Revenue Share by Companies, 2018-2023
Table 8. Global Companies Molecular Diagnosis of Rectal Cancer Product Type
Table 9. List of Global Tier 1 Molecular Diagnosis of Rectal Cancer Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Molecular Diagnosis of Rectal Cancer Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Molecular Diagnosis of Rectal Cancer Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Molecular Diagnosis of Rectal Cancer Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Molecular Diagnosis of Rectal Cancer Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Molecular Diagnosis of Rectal Cancer Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Molecular Diagnosis of Rectal Cancer Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Molecular Diagnosis of Rectal Cancer Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Molecular Diagnosis of Rectal Cancer Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Molecular Diagnosis of Rectal Cancer Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Molecular Diagnosis of Rectal Cancer Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Molecular Diagnosis of Rectal Cancer Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Molecular Diagnosis of Rectal Cancer Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Molecular Diagnosis of Rectal Cancer Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Molecular Diagnosis of Rectal Cancer Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Molecular Diagnosis of Rectal Cancer Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Molecular Diagnosis of Rectal Cancer Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Molecular Diagnosis of Rectal Cancer Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Molecular Diagnosis of Rectal Cancer Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Molecular Diagnosis of Rectal Cancer Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Molecular Diagnosis of Rectal Cancer Revenue, (US$, Mn), 2024-2030
Table 30. Kingmed Company Summary
Table 31. Kingmed Molecular Diagnosis of Rectal Cancer Product Offerings
Table 32. Kingmed Molecular Diagnosis of Rectal Cancer Revenue (US$, Mn) & (2018-2023)
Table 33. Kingmed Key News & Latest Developments
Table 34. Geneis Company Summary
Table 35. Geneis Molecular Diagnosis of Rectal Cancer Product Offerings
Table 36. Geneis Molecular Diagnosis of Rectal Cancer Revenue (US$, Mn) & (2018-2023)
Table 37. Geneis Key News & Latest Developments
Table 38. Unitedgene Company Summary
Table 39. Unitedgene Molecular Diagnosis of Rectal Cancer Product Offerings
Table 40. Unitedgene Molecular Diagnosis of Rectal Cancer Revenue (US$, Mn) & (2018-2023)
Table 41. Unitedgene Key News & Latest Developments
Table 42. Yin Feng Gene Company Summary
Table 43. Yin Feng Gene Molecular Diagnosis of Rectal Cancer Product Offerings
Table 44. Yin Feng Gene Molecular Diagnosis of Rectal Cancer Revenue (US$, Mn) & (2018-2023)
Table 45. Yin Feng Gene Key News & Latest Developments
Table 46. Inmedi Company Summary
Table 47. Inmedi Molecular Diagnosis of Rectal Cancer Product Offerings
Table 48. Inmedi Molecular Diagnosis of Rectal Cancer Revenue (US$, Mn) & (2018-2023)
Table 49. Inmedi Key News & Latest Developments
Table 50. Amoydx Company Summary
Table 51. Amoydx Molecular Diagnosis of Rectal Cancer Product Offerings
Table 52. Amoydx Molecular Diagnosis of Rectal Cancer Revenue (US$, Mn) & (2018-2023)
Table 53. Amoydx Key News & Latest Developments
Table 54. Genetronhealth Company Summary
Table 55. Genetronhealth Molecular Diagnosis of Rectal Cancer Product Offerings
Table 56. Genetronhealth Molecular Diagnosis of Rectal Cancer Revenue (US$, Mn) & (2018-2023)
Table 57. Genetronhealth Key News & Latest Developments
Table 58. Berryoncology Company Summary
Table 59. Berryoncology Molecular Diagnosis of Rectal Cancer Product Offerings
Table 60. Berryoncology Molecular Diagnosis of Rectal Cancer Revenue (US$, Mn) & (2018-2023)
Table 61. Berryoncology Key News & Latest Developments
Table 62. Topgen Company Summary
Table 63. Topgen Molecular Diagnosis of Rectal Cancer Product Offerings
Table 64. Topgen Molecular Diagnosis of Rectal Cancer Revenue (US$, Mn) & (2018-2023)
Table 65. Topgen Key News & Latest Developments
Table 66. Roche Company Summary
Table 67. Roche Molecular Diagnosis of Rectal Cancer Product Offerings
Table 68. Roche Molecular Diagnosis of Rectal Cancer Revenue (US$, Mn) & (2018-2023)
Table 69. Roche Key News & Latest Developments
Table 70. Qiagen Company Summary
Table 71. Qiagen Molecular Diagnosis of Rectal Cancer Product Offerings
Table 72. Qiagen Molecular Diagnosis of Rectal Cancer Revenue (US$, Mn) & (2018-2023)
Table 73. Qiagen Key News & Latest Developments
List of Figures
Figure 1. Molecular Diagnosis of Rectal Cancer Segment by Type in 2022
Figure 2. Molecular Diagnosis of Rectal Cancer Segment by Application in 2022
Figure 3. Global Molecular Diagnosis of Rectal Cancer Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Molecular Diagnosis of Rectal Cancer Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Molecular Diagnosis of Rectal Cancer Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Molecular Diagnosis of Rectal Cancer Revenue in 2022
Figure 8. By Type - Global Molecular Diagnosis of Rectal Cancer Revenue Market Share, 2018-2030
Figure 9. By Application - Global Molecular Diagnosis of Rectal Cancer Revenue Market Share, 2018-2030
Figure 10. By Type - Global Molecular Diagnosis of Rectal Cancer Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Molecular Diagnosis of Rectal Cancer Revenue Market Share, 2018-2030
Figure 12. By Application - Global Molecular Diagnosis of Rectal Cancer Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Molecular Diagnosis of Rectal Cancer Revenue Market Share, 2018-2030
Figure 14. By Region - Global Molecular Diagnosis of Rectal Cancer Revenue Market Share, 2018-2030
Figure 15. By Country - North America Molecular Diagnosis of Rectal Cancer Revenue Market Share, 2018-2030
Figure 16. US Molecular Diagnosis of Rectal Cancer Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Molecular Diagnosis of Rectal Cancer Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Molecular Diagnosis of Rectal Cancer Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Molecular Diagnosis of Rectal Cancer Revenue Market Share, 2018-2030
Figure 20. Germany Molecular Diagnosis of Rectal Cancer Revenue, (US$, Mn), 2018-2030
Figure 21. France Molecular Diagnosis of Rectal Cancer Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Molecular Diagnosis of Rectal Cancer Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Molecular Diagnosis of Rectal Cancer Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Molecular Diagnosis of Rectal Cancer Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Molecular Diagnosis of Rectal Cancer Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Molecular Diagnosis of Rectal Cancer Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Molecular Diagnosis of Rectal Cancer Revenue Market Share, 2018-2030
Figure 28. China Molecular Diagnosis of Rectal Cancer Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Molecular Diagnosis of Rectal Cancer Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Molecular Diagnosis of Rectal Cancer Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Molecular Diagnosis of Rectal Cancer Revenue, (US$, Mn), 2018-2030
Figure 32. India Molecular Diagnosis of Rectal Cancer Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Molecular Diagnosis of Rectal Cancer Revenue Market Share, 2018-2030
Figure 34. Brazil Molecular Diagnosis of Rectal Cancer Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Molecular Diagnosis of Rectal Cancer Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Molecular Diagnosis of Rectal Cancer Revenue Market Share, 2018-2030
Figure 37. Turkey Molecular Diagnosis of Rectal Cancer Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Molecular Diagnosis of Rectal Cancer Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Molecular Diagnosis of Rectal Cancer Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Molecular Diagnosis of Rectal Cancer Revenue, (US$, Mn), 2018-2030
Figure 41. Kingmed Molecular Diagnosis of Rectal Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Geneis Molecular Diagnosis of Rectal Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Unitedgene Molecular Diagnosis of Rectal Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Yin Feng Gene Molecular Diagnosis of Rectal Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Inmedi Molecular Diagnosis of Rectal Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Amoydx Molecular Diagnosis of Rectal Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Genetronhealth Molecular Diagnosis of Rectal Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Berryoncology Molecular Diagnosis of Rectal Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Topgen Molecular Diagnosis of Rectal Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Roche Molecular Diagnosis of Rectal Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Qiagen Molecular Diagnosis of Rectal Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
